Trial Profile
Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan- for Dapagliflozin in Management of Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jul 2019
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms REWARD
- Sponsors AstraZeneca
- 19 Jul 2018 Status changed from active, no longer recruiting to completed.
- 15 Mar 2018 Planned End Date changed from 28 Feb 2018 to 15 Jun 2018.
- 15 Mar 2018 Planned primary completion date changed from 28 Feb 2018 to 15 Jun 2018.